Hennion & Walsh Asset Management’s Phathom Pharmaceuticals PHAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.55M Buy
327,278
+181,346
+124% +$2.07M 0.1% 250
2026
Q1
$1.62M Buy
145,932
+30,951
+27% +$391K 0.05% 394
2025
Q4
$1.91M Buy
+114,981
New +$1.64M 0.07% 359
2023
Q4
Sell
-48,987
Closed -$508K 858
2023
Q3
$508K Sell
48,987
-9,671
-16% -$133K 0.03% 512
2023
Q2
$840K Buy
58,658
+616
+1% +$7.1K 0.05% 405
2023
Q1
$414K Sell
58,042
-1,364
-2% -$12K 0.03% 554
2022
Q4
$667K Buy
59,406
+4,735
+9% +$48.8K 0.04% 431
2022
Q3
$606K Sell
54,671
-1,833
-3% -$17.5K 0.04% 438
2022
Q2
$477K Buy
56,504
+5,452
+11% +$56.1K 0.03% 493
2022
Q1
$695K Buy
51,052
+20,158
+65% +$326K 0.04% 437
2021
Q4
$608K Buy
+30,894
New +$727K 0.03% 495

Other funds holding PHAT